Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hoppe

Showing results (191-200 of 287) with videos related to

Pageof 29
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 17, 2016
Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate CancerCurtis Bryant, Tamara L Smith, Randal H Henderson, et al.
The Lancet. Haematology|May 19, 2025
Radiate equity: the inclusion of radiation oncology and other specialties in lymphoma collaborative groupsOmran Saifi, Chelsea C Pinnix, Chris R Kelsey, et al.
Acta Oncologica (Stockholm, Sweden)|January 19, 2019
Impact of unfavorable factors on outcomes among inoperable stage II-IV Nonsmall cell lung cancer patients treated with proton therapyHe J Zhu, Romaine C Nichols, Randal H Henderson, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2025
Multimodality Artificial Intelligence for Involved-Site Radiation Therapy: Clinical Target Volume Delineation in High-Risk Pediatric Hodgkin LymphomaXin Tie, Sarah A Milgrom, Andrea C Lo, et al.
Blood|June 28, 2022
Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysisAkash Parekh, Frank G Keller, Kathleen M McCarten, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2008
Unresectable carcinoma of the paranasal sinuses: outcomes and toxicitiesBradford S Hoppe, Carl J Nelson, Daniel R Gomez, et al.
American Journal of Hematology|November 11, 2023
Incorporating radiation with anti-CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory non-Hodgkin lymphoma: A multicenter consensus approachOmran Saifi, Scott C Lester, William G Breen, et al.
Pediatric Blood & Cancer|May 27, 2023
Prognostic value of chest x-ray- and CT-defined large mediastinal adenopathy in high-risk pediatric Hodgkin lymphoma: A report from the Children's Oncology Group Study AHOD0831Andrea C Lo, Inki Lee, Qinglin Pei, et al.
International Journal of Particle Therapy|February 7, 2022
Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin LymphomaRaymond B Mailhot Vega, Sharon M Castellino, Qinglin Pei, et al.
International Journal of Particle Therapy|April 8, 2021
Postoperative or Salvage Proton Radiotherapy for Prostate Cancer After Radical ProstatectomyShivam M Kharod, Catherine E Mercado, Christopher G Morris, et al.
Pageof 29

Showing results (191-200 of 287) with videos related to

Sort By:
Pageof 29
International Journal of Radiation Oncology, Biology, Physics|April 17, 2016
Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate CancerCurtis Bryant, Tamara L Smith, Randal H Henderson, et al.
The Lancet. Haematology|May 19, 2025
Radiate equity: the inclusion of radiation oncology and other specialties in lymphoma collaborative groupsOmran Saifi, Chelsea C Pinnix, Chris R Kelsey, et al.
Acta Oncologica (Stockholm, Sweden)|January 19, 2019
Impact of unfavorable factors on outcomes among inoperable stage II-IV Nonsmall cell lung cancer patients treated with proton therapyHe J Zhu, Romaine C Nichols, Randal H Henderson, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2025
Multimodality Artificial Intelligence for Involved-Site Radiation Therapy: Clinical Target Volume Delineation in High-Risk Pediatric Hodgkin LymphomaXin Tie, Sarah A Milgrom, Andrea C Lo, et al.
Blood|June 28, 2022
Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysisAkash Parekh, Frank G Keller, Kathleen M McCarten, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2008
Unresectable carcinoma of the paranasal sinuses: outcomes and toxicitiesBradford S Hoppe, Carl J Nelson, Daniel R Gomez, et al.
American Journal of Hematology|November 11, 2023
Incorporating radiation with anti-CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory non-Hodgkin lymphoma: A multicenter consensus approachOmran Saifi, Scott C Lester, William G Breen, et al.
Pediatric Blood & Cancer|May 27, 2023
Prognostic value of chest x-ray- and CT-defined large mediastinal adenopathy in high-risk pediatric Hodgkin lymphoma: A report from the Children's Oncology Group Study AHOD0831Andrea C Lo, Inki Lee, Qinglin Pei, et al.
International Journal of Particle Therapy|February 7, 2022
Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin LymphomaRaymond B Mailhot Vega, Sharon M Castellino, Qinglin Pei, et al.
International Journal of Particle Therapy|April 8, 2021
Postoperative or Salvage Proton Radiotherapy for Prostate Cancer After Radical ProstatectomyShivam M Kharod, Catherine E Mercado, Christopher G Morris, et al.
Pageof 29